Aspire Private Capital’s TherapeuticsMD TXMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1
| Closed | -$2 | – | 593 |
|
|
2024
Q3 | $2 | Hold |
1
| – | – | ﹤0.01% | 681 |
|
|
2024
Q2 | $2 | Hold |
1
| – | – | ﹤0.01% | 692 |
|
|
2024
Q1 | $2 | Hold |
1
| – | – | ﹤0.01% | 723 |
|
|
2023
Q4 | $2 | Hold |
1
| – | – | ﹤0.01% | 705 |
|
|
2023
Q3 | $3 | Hold |
1
| – | – | ﹤0.01% | 701 |
|
|
2023
Q2 | $4 | Hold |
1
| – | – | ﹤0.01% | 674 |
|
|
2023
Q1 | $4 | Hold |
1
| – | – | ﹤0.01% | 654 |
|
|
2022
Q4 | $6 | Hold |
1
| – | – | ﹤0.01% | 653 |
|
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 664 |
|
|
2022
Q2 | $0 | Buy |
+1
| New | – | ﹤0.01% | 647 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 673 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 671 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 639 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 606 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 532 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 485 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 544 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 547 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 634 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 626 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 587 |
|